Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification to treat aggressive breast cancer-Reference-Cited by-同舟云学术

Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification to treat aggressive breast cancer

Published:2024 Issue:3 Volume:16 Page:1415-1427
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Liu Yu-Ling¹,Wang Tzu-Hao¹,Yeh Nien-Tzu¹,Huang Wei-Jen¹,Tzang Bor-Show²³⁴⁵,Wu I-Ting²,Chin Hao-Yang²,Hu Shang-Hsiu⁶^ORCID,Hsu Tsai-Ching²⁴⁵,Chiang Wen-Hsuan¹^ORCID

Affiliation:

1. Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan

2. Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan

3. Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan

4. Immunology Research Center, Chung Shan Medical University, Taichung 402, Taiwan

5. Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan

6. Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 300, Taiwan

Abstract

Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification was developed to treat aggressive breast cancer.

Funder

National Science and Technology Council

National Chung-Hsing University

Chung Shan Medical University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NR/D3NR05637F

Reference54 articles.

1. Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy